Vaccine Considerations in Patients with Cancer Receiving SACT (including COVID-19)

Complimentary Members Only Webinar on April 12, 2021
12:00 PDT, 13:00 MDT, 13:00 CST, 15:00 EDT, 16:00 ADT, 20:00 GMT

Registration complimentary for PAID members of CAPhO, ISOPP and BOPA.

Register here
(please register with the same email you use for the BOPA website)

Join us for this member’s only complimentary panel discussion on the timely topic of vaccine considerations in cancer patients. All presenters are authors of the paper ‘Clinician FAQs And Guidance On Covid-19 Vaccine For Patients Receiving Systemic Anti-Cancer Therapy (SACT)’ published by the UK Chemotherapy Board.

The presenters for this 90 minute webinar are:

• Deborah Enting, SACT Lead & Consultant Medical Oncologist, Guy’s & St Thomas’ NHS Foundation Trust
• Rajinder Nijjar, Clinical Lead Pharmacist – Oncology, Barts Health NHS Trust
• Calum Polwart, Specialist Pharmacist – Oncology, South Tees Hospitals NHS Foundation Trust
• Nisha Shaunak, Lead Pharmacist – Oncology, Guy’s & St Thomas’ NHS Foundation Trust

Click for more information here

To join BOPA as a PAID member click here

We look forward to seeing you on April 12!

Glenn Myers
Canadian Association of Pharmacy in Oncology
CAPhO Education Committee Chair Pharmacist – Advanced
On behalf of the
International Society of Oncology Pharmacy Practitioners (ISOPP)
British Oncology Pharmacy Association (BOPA)

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article